DATE | HS_CODE | Product Description | Trademark | Country | Net Weight | Statistical Cost | Place | Shipper Name | Consignee Name |
---|
2017-09-07 | 3002150000 | IMMUNOLOGICAL retail products (VED 2H) GENFAKSON (interferon beta-1a) solution for subcutaneous injection MLN.ME 12 (44 mcg) (syringe) of 0.5 ml (44 mcg) X 3 (paper cartons) - 25200 UE. SERIES IN117B valid until 07.2019, SERIES IN118B | GENFAKSON | *** | 1023.37 | 3687726,09 | MOSCOW | ***** | ***** |
2017-09-08 | 3002150000 | LEK.SR-VA, SOD. Immunological products, RASF. The unit dosage form and packaging for retail sale (NOT FOR VETERINARY) Orensakh (abatacept) R-P for subcutaneous administration of 125 mg / ml (C automatic retractable SYRINGE NEEDLE) 1.007 ML | Ourense | *** | 278.9 | 1291773,45 | MOSCOW | ***** | ***** |
2017-09-11 | 3002150000 | LEK.PREPARAT for honey. APPLICATIONS "IN BULK" NOT for retail sale: Humira (adalimumab) [solution for subcutaneous injection, 40mg / 0.8ML (SYRINGE) 0.8ML X1 + (NAPKIN ALCOHOL) X1] X1 (Blister) - 10000 conveying packs (1 pack contains 2 | Humira | *** | 763 | 6494597,92 | MOSCOW | ***** | ***** |
2017-09-11 | 3002150000 | IMMUNOLOGICAL retail products (VED 2H) GENFAKSON (interferon beta-1a) solution for subcutaneous injection MLN.ME 12 (44 mcg) (syringe) of 0.5 ml (44 mcg) X 3 (paper cartons) - 20464UP. SERIES IN119B, IN120B valid until 08.2019 The dash | GENFAKSON | *** | 831.04 | 3012642,06 | MOSCOW | ***** | ***** |
2017-09-12 | 3002150000 | IMMUNOBIOLOGICAL DRUGS AS DRUGS, packaged for retail sale, for veterinary NO: Xolair / XOLAIR / (omalizumab) lyophilisate FOR PREPARING SOLUTION FOR SUBCUTANEOUS ADMINISTRATION OF 150 MG (BOTTLE) | "Xolair" SWITZERLAND | *** | 88.14 | 838551,1 | MOSCOW | ***** | ***** |
2017-09-19 | 3002150000 | IMMUNOBIOLOGICAL DRUGS AS DRUGS, packaged for retail sale, for veterinary NO: Xolair / XOLAIR / (omalizumab) lyophilisate FOR PREPARING SOLUTION FOR SUBCUTANEOUS ADMINISTRATION OF 150 MG (BOTTLE) | "Xolair" SWITZERLAND | *** | 134.85 | 1272817,58 | MOSCOW | ***** | ***** |
2017-09-21 | 3002150000 | IMMUNOLOGICAL retail products (VED 2H) GENFAKSON (interferon beta-1a) solution for subcutaneous injection MLN.ME 12 (44 mcg) (syringe) of 0.5 ml (44 mcg) X 3 (paper cartons) - 26342 UE. SERIES IN123B, IN124B, IN125B valid until 08.2019 | GENFAKSON | *** | 1069.75 | 3802435,46 | MOSCOW | ***** | ***** |
2017-09-21 | 3002150000 | IMMUNOLOGICAL retail products (VED 2H) GENFAKSON (interferon beta-1a) solution for subcutaneous injection MLN.ME 12 (44 mcg) (syringe) of 0.5 ml (44 mcg) X 3 (paper cartons) - 25179 UE. SERIES IN121B, IN122B valid until 08.2019 .SHTRIH- | GENFAKSON | *** | 1022.52 | 3634557,83 | MOSCOW | ***** | ***** |
2017-09-22 | 3002150000 | Medicament for retail sale (VED, 1H): Roferon-A (interferon alfa-2A) [solution for subcutaneous injection, 3 million IU / 0.5 ml (ampin) X 1 + ASEPTIC injection needle (TANK) X1] X 1 (paper cartons) - 8002 MPS-IVLC 21 February. | Roferon-A, SWITZERLAND | *** | 164.829 | 87775,14 | MOSCOW | ***** | ***** |
2017-11-13 | 3002150000 | IMMUNOLOGICAL products, medicinal -VA for retail sale (VED, XX): Enbrel (Etanercept) [SOLUTION FOR SUBCUTANEOUS ADMINISTRATION OF 50 MG / ML (SYRINGE) 1 ml (50 mg) X 4 + (napkins) X 4], X 1 (cardboard pack) - 2991 UP.SERIYA T66654 valid until 03.2020, | Pfizer, PFIZER, Enbrel | *** | 388.83 | 2162941,12 | MOSCOW | ***** | ***** |